DoctorWhat

BSV Plummeting, In Free Fall...More Destruction Ahead!!!

Short
DoctorWhat Updated   
BITFINEX:BSVUSD   None
The whales are evolving into cows and crawling out of the ocean, lowering the water levels for everyone, and they're not done!!! We've hit the level we were at just before the run to $380, and there's more room to fall! We're under 50 on the daily RSI for the first time since the courier news came out in court, and there's more room to hit oversold levels! $240 is the next target, followed by $180! Probably won't fall further, but who knows?!?!?! Get out while you can if you haven't already!!!
Comment:
I actually thought we were much closer to the bottom than I let on in this chart. I wanted to see if posting FUD would affect the outcome. Doesn't seem to have done so, and in fact, it's ripping back up the other way!

I also seem to have tapped into a nerve here, ongoing elsewhere, in the BSV/anti-BSV war. What say you who despise Craig Wright and BSV? Which project do you prefer and why? Please keep it constructive. Thanks!
Comment:
$285ish looking like a hard floor after five out of six days opening or closing on that value, without more than a wick below. Hidden bullish divergence on the daily suggestive of a price increase in the future.
Comment:
I heard a rumor from a reliable source that we're going to $250. The same source predicts three figures large and maybe even four figures before long.
Comment:
P.S. "Long" is weeks to months.
Comment:
BTC buoying up the price a little here.
Trade closed: target reached:
Went to $250, and wicked under $205. Now hung up at the bottom of the wedge that formed up after the courier news release. Indicators suggest movement in either direction. Next stop could be $160 to $180 or it could go back to $350ish.

$240 was hit, and returned to, so I'm closing this idea.

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.